# Olga Danilchanka

> Olga Danilchanka is a Series B investor at MRL Ventures Fund backing Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug…

- Type: Angel Investor
- Fund: [MRL Ventures Fund](https://shizune.co/investors/profile/mrl-venture-fund)
- Location: Cambridge, United States
- Total investments: 1
- Last investment: May 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/olga-danilchanka-1a40a360

Olga Danilchanka is a Series B investor at MRL Ventures Fund in Cambridge focused on Health Care and Therapeutics. Olga Danilchanka

## Contacts

5 contacts available for Olga Danilchanka: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/olga-danilchanka-e227?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PAQ Therapeutics | PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy, the body's most versatile mechanism for natural cellular degradation. | $39M | Series B | May 05, 2025 |  |

1 of 1 investments shown.

## Co-investors
- [Bayland Capital](https://shizune.co/investors/profile/bayland-capital) — VC Fund, 1 deal together
- [BioTrack Capital](https://shizune.co/investors/profile/biotrack-capital) — VC Fund, 1 deal together
- [Johnson & Johnson Innovation](https://shizune.co/investors/profile/johnson-johnson-innovation-jjdc) — VC Fund, 1 deal together
- LAV Fund — VC Fund, 1 deal together
- [Sherpa Healthcare Partners](https://shizune.co/investors/profile/sherpa-venture-capital) — VC Fund, 1 deal together

## About MRL Ventures Fund

VC Fund · Cambridge, United States

The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highlydifferentiated new medicines to improve human health.

3 contacts available at MRL Ventures Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Olga Danilchanka | Partner | — |
| Peter Dudek | Partner | https://shizune.co/investors/profile/peter-dudek-08b4 |
| Reza Halse | Partner | — |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Olga Danilchanka invest in?

Olga Danilchanka invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Olga Danilchanka?

Public channels for Olga Danilchanka include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Olga Danilchanka last invest?

The most recent investment recorded for Olga Danilchanka closed in May 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co